针对失眠的非侵入性神经刺激的最新进展:一篇综述
1Department of Psychological, Huai'an No.3 People's Hospital, Huaian Second Clinical College of Xuzhou Medical University, Huaian, People's Republic of China.
Nature and science of sleep
|May 21, 2025
概括
非侵入性神经刺激为失眠治疗提供了有希望的替代方案,解决了药物治疗和认知行为疗法等传统疗法的局限性. 这篇评论探讨了虚拟现实和跨脑磁刺激等技术,以改善睡眠健康.
科学领域:
- 睡眠科学 睡眠科学
- 神经科学是一个神经科学.
- 医疗技术 医疗技术 医学技术
背景情况:
- 失眠是一个重要的公共卫生问题,具有有限的疗效和传统治疗的潜在副作用,如镇静催眠药和认知行为疗法.
- 物理疗法正在成为可行的替代方案,比基于药物和行为干预措施提供优势.
- 非侵入性神经调节技术正在获得失眠治疗的吸引力,但公众意识和研究评论仍然不足.
研究的目的:
- 审查最近在治疗失眠的非侵入性神经刺激技术的进展.
- 提供这些新型治疗方法的技术类型,原则和疗效的概述.
- 为医疗保健提供者和患者提供关于失眠管理新兴选择的信息.
主要方法:
- 对不眠症的非侵入性神经刺激的最新研究进行系统审查.
- 专注于包括虚拟现实,生物反,跨磁刺激,跨电刺激和跨皮耳迷走神经刺激在内的技术.
- 对当前关于这些神经调节策略的应用和有效性的文献进行分析.
主要成果:
- 非侵入性神经刺激技术显示出作为有效的失眠治疗的潜力,提供了比传统方法更少不良影响的替代方案.
- 诸如虚拟现实,生物反和不同形式的神经刺激等各种模式在管理失眠症状方面显示出有前途.
- 该评论强调了越来越多的证据支持这些新的睡眠科学方法.
结论:
- 非侵入性神经刺激为失眠治疗提供了一个有希望的途径,补充或取代传统疗法.
- 需要进一步的研究和全面的审查,以充分理解这些技术的潜力和优化应用.
- 这些进展为改善失眠管理提供了希望,并为未来睡眠科学的发展做出了贡献.
更多相关视频
08:44Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice
Published on: February 21, 2021
4.2K
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.1K
相关概念视频
01:19Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143
01:27Insomnia
78
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
78